Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
BPI Contributor
May 4, 2017
20 Min View
Date: May 4, 2017
Duration: 20 Min
This webcast features: James Brady, PhD, VP of Technical Applications and Customer Support, MaxCyte, Inc.
Moving bispecific and complex protein therapeutics from the bench to the clinic requires a scalable process that is consistent and reproducible while delivering a biologically active product. MaxCyte’s delivery platform is a high performance, electroporation-based technology that can rapidly generate milligram to gram quantities of protein in the cell line of choice.
You will learn:
How to express quality bi-specific antibodies, bi-specific T cell engaging (BITE) molecules, tribodies, and full IgGs in CHO cells
The importance of analyzing protein quality and glycosylation patterns to understand how transiently produced proteins mimic product qualities of stably produced proteins
About efficiently producing other difficult macromolecules, including viral vectors and multi-subunit drug targets, such as ion channels
How transient transfection using MaxCyte’s Flow Electroporation™ can delay or eliminate stable cell line generation while maintaining the integrity of candidate selection during biotherapeutic development
About the Author(s)
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More